The decline of androgen levels in elderly men and its clinical and therapeutic implications

JM Kaufman, A Vermeulen - Endocrine reviews, 2005 - academic.oup.com
Aging in men is accompanied by a progressive, but individually variable decline of serum
testosterone production, more than 20% of healthy men over 60 yr of age presenting with …

Estradiol in elderly men

A Vermeulen, JM Kaufman, S Goemaere… - The aging …, 2002 - Taylor & Francis
The role of estrogens in male physiology has become more evident, as a consequence of
the discovery of human models of estrogen deficiency such as estrogen resistance or …

[HTML][HTML] Assessment of muscle function and physical performance in daily clinical practice: a position paper endorsed by the European Society for Clinical and …

…, B Dawson-Hughes, JA Kanis, JM Kaufman… - Calcified tissue …, 2019 - Springer
It is well recognized that poor muscle function and poor physical performance are strong
predictors of clinically relevant adverse events in older people. Given the large number of …

A critical evaluation of simple methods for the estimation of free testosterone in serum

…, L Verdonck, JM Kaufman - The Journal of Clinical …, 1999 - academic.oup.com
The free and nonspecifically bound plasma hormone levels generally reflect the clinical
situation more accurately than total plasma hormone levels. Hence, it is important to have …

[HTML][HTML] Effect of risedronate on the risk of hip fracture in elderly women

…, RD Wasnich, M Greenwald, JM Kaufman… - New England journal …, 2001 - Mass Medical Soc
Background Risedronate increases bone mineral density in elderly women, but whether it
prevents hip fracture is not known. Methods We studied 5445 women 70 to 79 years old who …

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations

…, WJ Hellstrom, LJ Gooren, JM Kaufman… - European journal of …, 2008 - academic.oup.com
Demographic data clearly demonstrate that the percentage of the population in the older
age group is increasing. Androgen deficiency in the aging male has become a topic of …

[HTML][HTML] Intravenous zoledronic acid in postmenopausal women with low bone mineral density

…, A Widmer, JP Devogelaer, JM Kaufman… - … England Journal of …, 2002 - Mass Medical Soc
Background Bisphosphonates are effective agents for the management of osteoporosis.
Their low bioavailability and low potency necessitate frequent administration on an empty …

The effect of teriparatide [human parathyroid hormone (1–34)] therapy on bone density in men with osteoporosis

…, U Syversen, A Diez‐Perez, JM Kaufman… - Journal of bone and …, 2003 - academic.oup.com
Teriparatide [rhPTH(1–34)] increases bone mineral density and reduces the risk of vertebral
fracture in women. We randomized 437 men with spine or hip bone mineral density more …

[PDF][PDF] Investigation, treatment and monitoring of late-onset hypogonadism in males

…, R Swerdloff, HM Behre, LJ Gooren, JM Kaufman… - The Aging …, 2005 - Taylor & Francis
Androgen deficiency in the aging male has become a topic of increasing interest and debate
throughout the world. The demographics clearly demonstrate the increasing percentage of …

Two‐year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double‐blind, placebo‐controlled …

…, E Seeman, NE Lane, JM Kaufman… - … : Official Journal of …, 2001 - Wiley Online Library
Objective To evaluate the continued efficacy and safety of alendronate (ALN) for up to 2
years in patients receiving glucocorticoids. Methods This is a 12‐month extension of a …